Glyoxalase 1 Regulates Methylglyoxal-Derived Nucleic Acid Adduct Burden.
- 1Department of Diabetes and Cancer Metabolism, City of Hope National Medical Center, Duarte, California91010, United States.
Abstract
Increased metabolic stress associated with diabetes and cancer increases the level of reactive dicarbonyl molecules that covalently modify nucleic acids. Methylglyoxal (MG), one of the most abundant endogenous dicarbonyl electrophiles, reacts with guanine bases in DNA and RNA to form covalent adducts that compromise genomic and RNA integrity. The primary MG-derived adduct in DNA is N2-carboxyethyl deoxyguanosine (CEdG), and in RNA, it is N2-carboxyethyl guanosine (CEG). CEdG is mutagenic, while CEG decreases mRNA stability and impairs translation. To prevent adduct formation, cells utilize the glyoxalase pathway, which is the primary pathway for detoxifying MG. Glyoxalase 1 (GLO1) is the first enzyme in this pathway. While GLO1 is frequently dysregulated in metabolic disease and cancer, its role in regulating MG-induced nucleic acid adduct burden and the downstream functional consequences remains incompletely defined. Here, we demonstrate that the genetic ablation of GLO1 significantly increases the accumulation of MG-derived DNA and RNA adducts. We found that an elevated CEdG adduct burden is associated with increased DNA strand breaks, whereas increased CEG modifications are associated with reduced translational efficiency. These findings establish GLO1 as a critical regulator of the endogenous nucleic acid modification burden and mechanistically link metabolic stress-derived chemical lesions to genome instability and translational dysfunction.
Related
- Mast cell-derived histamine negatively regulates hematopoiesis
- Sodium Butyrate Inhibits Glyoxalase 1 to Reverse D-Lactate-associated Drug Resistance in Cancer Cells
- cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: Quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II)
- Female-specific associations of glyoxalase 1 polymorphisms with schizophrenia in a Han Chinese case–control study
- Methylglyoxal Impairs Mitochondrial Bioenergetics and Microglial Functions
BibTeX
@article{battad2026glyoxalase,
title = {{Glyoxalase 1 Regulates Methylglyoxal-Derived Nucleic Acid Adduct Burden.}},
author = {Alana Battad and Francisco Nunez and Seigmund W T Lai and Elise Desjarlais and Sarah C Shuck},
journal = {Chemical research in toxicology},
year = {2026},
month = sep,
doi = {10.1021/acs.chemrestox.6c00169},
url = {https://europepmc.org/article/MED/42915731},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Glyoxalase 1 Regulates Methylglyoxal-Derived Nucleic Acid Adduct Burden.
AU - Alana Battad
AU - Francisco Nunez
AU - Seigmund W T Lai
AU - Elise Desjarlais
AU - Sarah C Shuck
PY - 2026
DA - 2026/09/01
JO - Chemical research in toxicology
DO - 10.1021/acs.chemrestox.6c00169
UR - https://europepmc.org/article/MED/42915731
AB - Increased metabolic stress associated with diabetes and cancer increases the level of reactive dicarbonyl molecules that covalently modify nucleic acids. Methylglyoxal (MG), one of the most abundant endogenous dicarbonyl electrophiles, reacts with guanine bases in DNA and RNA to form covalent adducts that compromise genomic and RNA integrity. The primary MG-derived adduct in DNA is N2-carboxyethyl deoxyguanosine (CEdG), and in RNA, it is N2-carboxyethyl guanosine (CEG). CEdG is mutagenic, while CEG decreases mRNA stability and impairs translation. To prevent adduct formation, cells utilize the glyoxalase pathway, which is the primary pathway for detoxifying MG. Glyoxalase 1 (GLO1) is the first enzyme in this pathway. While GLO1 is frequently dysregulated in metabolic disease and cancer, its role in regulating MG-induced nucleic acid adduct burden and the downstream functional consequences remains incompletely defined. Here, we demonstrate that the genetic ablation of GLO1 significantly increases the accumulation of MG-derived DNA and RNA adducts. We found that an elevated CEdG adduct burden is associated with increased DNA strand breaks, whereas increased CEG modifications are associated with reduced translational efficiency. These findings establish GLO1 as a critical regulator of the endogenous nucleic acid modification burden and mechanistically link metabolic stress-derived chemical lesions to genome instability and translational dysfunction.
SN - 0893-228X
SN - 1520-5010
ER -